115 related articles for article (PubMed ID: 28988621)
41. Dimers and multimers of monoclonal IgG1 exhibit higher in vitro binding affinities to Fcgamma receptors.
Luo Y; Lu Z; Raso SW; Entrican C; Tangarone B
MAbs; 2009; 1(5):491-504. PubMed ID: 20065648
[TBL] [Abstract][Full Text] [Related]
42. The binding epitopes of human CD16 (Fc gamma RIII) monoclonal antibodies. Implications for ligand binding.
Tamm A; Schmidt RE
J Immunol; 1996 Aug; 157(4):1576-81. PubMed ID: 8759741
[TBL] [Abstract][Full Text] [Related]
43. Charge heterogeneity: Basic antibody charge variants with increased binding to Fc receptors.
Hintersteiner B; Lingg N; Zhang P; Woen S; Hoi KM; Stranner S; Wiederkum S; Mutschlechner O; Schuster M; Loibner H; Jungbauer A
MAbs; 2016; 8(8):1548-1560. PubMed ID: 27559765
[TBL] [Abstract][Full Text] [Related]
44. Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice.
Braster R; Grewal S; Visser R; Einarsdottir HK; van Egmond M; Vidarsson G; Bögels M
PLoS One; 2017; 12(5):e0177736. PubMed ID: 28542406
[TBL] [Abstract][Full Text] [Related]
45. Discovery and Characterization of Histidine Oxidation Initiated Cross-links in an IgG1 Monoclonal Antibody.
Xu CF; Chen Y; Yi L; Brantley T; Stanley B; Sosic Z; Zang L
Anal Chem; 2017 Aug; 89(15):7915-7923. PubMed ID: 28635253
[TBL] [Abstract][Full Text] [Related]
46. IgG Fc variant cross-reactivity between human and rhesus macaque FcγRs.
Boesch AW; Miles AR; Chan YN; Osei-Owusu NY; Ackerman ME
MAbs; 2017 Apr; 9(3):455-465. PubMed ID: 28055295
[TBL] [Abstract][Full Text] [Related]
47. Crucial role of FcgammaRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera.
Rodriguez ME; van der Pol WL; Sanders LA; van de Winkel JG
J Infect Dis; 1999 Feb; 179(2):423-33. PubMed ID: 9878027
[TBL] [Abstract][Full Text] [Related]
48. FcgammaRIIa expression with FcgammaRI results in C-reactive protein- and IgG-mediated phagocytosis.
Bodman-Smith KB; Gregory RE; Harrison PT; Raynes JG
J Leukoc Biol; 2004 Jun; 75(6):1029-35. PubMed ID: 15075346
[TBL] [Abstract][Full Text] [Related]
49. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.
Davies J; Jiang L; Pan LZ; LaBarre MJ; Anderson D; Reff M
Biotechnol Bioeng; 2001 Aug; 74(4):288-94. PubMed ID: 11410853
[TBL] [Abstract][Full Text] [Related]
50. Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile.
Bruggeman CW; Dekkers G; Bentlage AEH; Treffers LW; Nagelkerke SQ; Lissenberg-Thunnissen S; Koeleman CAM; Wuhrer M; van den Berg TK; Rispens T; Vidarsson G; Kuijpers TW
J Immunol; 2017 Jul; 199(1):204-211. PubMed ID: 28566370
[TBL] [Abstract][Full Text] [Related]
51. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity.
Shields RL; Lai J; Keck R; O'Connell LY; Hong K; Meng YG; Weikert SH; Presta LG
J Biol Chem; 2002 Jul; 277(30):26733-40. PubMed ID: 11986321
[TBL] [Abstract][Full Text] [Related]
52. Expression of human FcgammaRIIIa as a GPI-linked molecule on CHO cells to enable measurement of human IgG binding.
Armour KL; Smith CS; Clark MR
J Immunol Methods; 2010 Mar; 354(1-2):20-33. PubMed ID: 20138184
[TBL] [Abstract][Full Text] [Related]
53. Effect of isotype on internalization and cytotoxicity of CD19-ricin A immunotoxins.
van Oosterhout YV; van den Herik-Oudijk IE; Wessels HM; de Witte T; van de Winkel JG; Preijers FW
Cancer Res; 1994 Jul; 54(13):3527-32. PubMed ID: 7516821
[TBL] [Abstract][Full Text] [Related]
54. Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation.
Liu D; Ren D; Huang H; Dankberg J; Rosenfeld R; Cocco MJ; Li L; Brems DN; Remmele RL
Biochemistry; 2008 May; 47(18):5088-100. PubMed ID: 18407665
[TBL] [Abstract][Full Text] [Related]
55. Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.
Lu Y; Vernes JM; Chiang N; Ou Q; Ding J; Adams C; Hong K; Truong BT; Ng D; Shen A; Nakamura G; Gong Q; Presta LG; Beresini M; Kelley B; Lowman H; Wong WL; Meng YG
J Immunol Methods; 2011 Feb; 365(1-2):132-41. PubMed ID: 21185301
[TBL] [Abstract][Full Text] [Related]
56. Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.
Hristodorov D; Mladenov R; Brehm H; Fischer R; Barth S; Thepen T
MAbs; 2014; 6(5):1283-9. PubMed ID: 25517313
[TBL] [Abstract][Full Text] [Related]
57. Enhanced antibody-dependent cellular phagocytosis by chimeric monoclonal antibodies with tandemly repeated Fc domains.
Nagashima H; Ootsubo M; Fukazawa M; Motoi S; Konakahara S; Masuho Y
J Biosci Bioeng; 2011 Apr; 111(4):391-6. PubMed ID: 21215693
[TBL] [Abstract][Full Text] [Related]
58. Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.
Repp R; Kellner C; Muskulus A; Staudinger M; Nodehi SM; Glorius P; Akramiene D; Dechant M; Fey GH; van Berkel PH; van de Winkel JG; Parren PW; Valerius T; Gramatzki M; Peipp M
J Immunol Methods; 2011 Oct; 373(1-2):67-78. PubMed ID: 21855548
[TBL] [Abstract][Full Text] [Related]
59. Affinity capillary electrophoresis - mass spectrometry permits direct binding assessment of IgG and FcγRIIa in a glycoform-resolved manner.
Gstöttner C; Knaupp A; Vidarsson G; Reusch D; Schlothauer T; Wuhrer M; Domínguez-Vega E
Front Immunol; 2022; 13():980291. PubMed ID: 36159782
[TBL] [Abstract][Full Text] [Related]
60. Enhancement of Immune Effector Functions by Modulating IgG's Intrinsic Affinity for Target Antigen.
Mazor Y; Yang C; Borrok MJ; Ayriss J; Aherne K; Wu H; Dall'Acqua WF
PLoS One; 2016; 11(6):e0157788. PubMed ID: 27322177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
